出生次序和非霍奇金淋巴瘤(NHL)的正相关性是由于早期生活中感染可能性增加影响。
Positive associations between birth order and non-Hodgkin lymphoma (NHL) have been interpreted as an effect of increased likelihood of early-life exposure to infections.
早前有研究认为丙型肝炎病毒（HVC）的感染与某些肝癌和非霍奇金淋巴瘤亚型的风险增加相关。
The hepatitis C virus (HVC) had been linked previously to increased risk of a certain liver cancer and subtypes of non-Hodgkin lymphoma.
它对血细胞的毒性作用已得到很好地记载，而且已知它导致不同类型的白血病、多发性骨髓瘤和非霍奇金淋巴瘤。
Its toxic effects on blood cells are well documented and it's known to cause different kinds of leukaemia, multiple myeloma and non-Hodgkin lymphoma.
目的了解多中心协作化疗方案(MCP方案)对急性淋巴细胞白血病(all)和非霍奇金淋巴瘤(NHL)患儿肾脏功能的影响。
Objective to investigate the renal damages in children with acute lymphoblastic leukemia (ALL) and non-Hodgkin's lymphoma (NHL) who received the intensive multicenter-protocols (MCP).
CD4计数低、艾滋病病毒载量高以及有无结合抗逆转录病毒治疗(cART)均会使卡波西氏肉瘤和非霍奇金淋巴瘤患病风险增加。
Increased risk of Kaposi's sarcoma and non-Hodgkin's lymphoma was associated with lower CD4 count, higher HIV viral load and a lack of combination antiretroviral therapy (cART).
淋巴瘤可分为两大类：霍奇金淋巴瘤和其他的淋巴瘤，被称作非霍奇金淋巴瘤。
The lymphomas are divided into two major categories: Hodgkin lymphoma and all other lymphomas, called non-Hodgkin lymphomas.
淋巴瘤指淋巴系统的恶性肿瘤。这种疾病可以分为霍奇金病淋巴瘤和非霍奇金病淋巴瘤，其中后者较为常见。
Lymphoma refers to a malignancy of the lymph system. The disease is divided into Hodgkin's disease and Non-Hodgkin's lymphoma with the latter being much more common.
通常分为两型︰霍奇金氏病和非霍奇金氏淋巴瘤，每一型又可进一步细分。这两种类型都需要靠活组织检查来诊断，常取自淋巴结。
The two major types, Hodgkin disease and non-Hodgkin lymphoma, each have several subtypes. Diagnosis of either type requires Biopsy, usually from the lymph nodes.
结论：IP方案治疗复发和难治性非霍奇金淋巴瘤的疗效比较满意，其毒性能够耐受，经对症处理均能恢复。
Conclusion: IP regimen can achieve a satisfied results in the treatment of recurrent and refractory Non-Hodgkin's lymphoma with well tolerated toxicity.
目的评价CHEP和CHOP方案治疗非霍奇金淋巴瘤(NHL)的疗效和毒性。
Objective Therapeutic effect and toxicity of CHEP and CHOP chemotherapy in the treatment of non Hodgkin's lymphoma (NHL) were compared.
方法回顾性分析经病理证实的21例骨原发性非霍奇金淋巴瘤的放射学和MRI表现。
Methods A retrospective analysis was performed to assess the radiological and MRI appearance of 21 cases confirmed to be primary bone non-Hodgkin's lymphomas by pathology.
目的：探讨鼻咽喉非霍奇金淋巴瘤的诊断、治疗和预后。
Objective: To discuss the diagnosis, treatment and prognosis of the primary non-Hodgkin lymphoma in nose, pharynx and larynx.
目的：观察国产表柔比星为主的联合化疗方案治疗非霍奇金淋巴瘤、乳腺癌、非小细胞肺癌的疗效和不良反应。
Objective:To observe the efficacy and toxicity of domestic epirubicin in treatment of non Hodgkin's lymphoma, breast cancer, and non small cell lung cancer.
目的探讨IMOP方案治疗非霍奇金氏淋巴瘤的疗效和毒性。
Objective: To evaluate the efficacy and toxicity of IMOP regimen to treat non-Hodgkin′s lymphoma.
目的：观察IP方案治疗复发和难治性非霍奇金淋巴瘤的疗效和毒性反应。
Objective: to observe the effect and side effects of IP regimen for patients with recurrent and refractory Non-Hodgkin's lymphoma.
方法：对76例经病理证实的咽淋巴环非霍奇金淋巴瘤的冠状及横断平扫和增强扫描的CT影像学特征进行回顾性分析。
Methods: We selected 76 pathologically proven cases of NHL in pharyngeal lymph chain with retrospective analysis of the imaging characteristics on coronal and transverse plain and enhanced ct scans.
目的评价德国NHL-BFM-90方案治疗中国儿童青少年B细胞非霍奇金淋巴瘤（B-NHL）的疗效和毒性。
Objectives To evaluate the efficacy and toxicity of the B-NHL-BFM-90 protocol in the treatment of Chinese childhood and adolescent B-cell non-Hodgkin's lymphomas(B-NHL).
虽然一些癌症已知和HIV相关，比如卡波济肉瘤，非霍奇金淋巴瘤和宫颈癌，但很少有对非艾滋病相关癌症的风险有指导作用的研究。
Although some cancers are known to be associated with HIV, such as Kaposi's sarcoma, non-Hodgkin's lymphoma and cervical cancer, limited research has been conducted on risk of non-AIDS cancers.
细胞非霍奇金淋巴瘤组织CD 22表达和临床病理特征的关系需进一步研究。
CD22 expression in B cell NHL tissue and its relationship with clinicopathological characteristics needs further study.
依帕珠单抗和钇-90标记的依帕珠单抗，用于B细胞非霍奇金淋巴瘤。
Epratuzumab and 90Y Epratuzumab for B cell non-Hodgkin lymphoma.
依帕珠单抗和钇-90标记的依帕珠单抗，用于B细胞非霍奇金淋巴瘤。
Epratuzumab and 90Y Epratuzumab for B cell non-Hodgkin lymphoma.
应用推荐